BioCentury | Mar 14, 2019
Translation in Brief

Bacteriophages: double-edged swords

...last month, the University of Utah School of Medicine team showed in mice that a bacteriophage cocktail...
BioCentury | Mar 4, 2019
Distillery Therapeutics

New bacteriophage-related therapeutic strategies for colitis and colorectal cancer

...Cancer; gastrointestinal INDICATION: Colorectal cancer; colitis Patient sample and mouse studies suggest an E. coli bacteriophage cocktail...
...TLR9. In a mouse model of E. coli -aggravated colorectal cancer, an oral E. coli bacteriophage cocktail...
BioCentury | Aug 31, 2017
Product R&D

Cutting through resistance

Most companies employing CRISPR- Cas9 for therapeutics are using it to edit human cells, but Locus Biosciences Inc. is betting the lesser-known CRISPR- Cas3 system will do a better job of treating bacterial infections and...
BioCentury | Feb 28, 2017
Distillery Therapeutics

Infectious disease

...INDICATION: Cholera Mouse and rabbit studies suggest a bacteriophage cocktail could help prevent cholera infection during an...
...the phages, but none were resistant to all three. Next steps could include testing the bacteriophage cocktail...
BioCentury | Oct 19, 2015
Clinical News

AmpliPhi BioSciences preclinical data

...In neutropenic, immunocompromised mice inoculated with Staphylococcus aureus, the 2 highest doses of AmpliPhi’s intranasal bacteriophage cocktail...
...cocktail of 4 bacteriophages against S. aureus isolates. AmpliPhi Biosciences Corp. (NYSE-M:APHB), Richmond, Va. Product: Bacteriophage cocktail...
Items per page:
1 - 5 of 5